European Association of Euro-Pharmaceutical Companies

October 2017

BAEPD’s view is that the key priority must be to retain the existing benefits enjoyed by the UK through the well-established regional regime of exhaustion of rights within the EU. Although BAEPD does not oppose the idea of international exhaustion in principle, it would be very difficult, costly and time consuming to implement. BAEPD therefore believes that it should not be allowed to obstruct the essential need to secure the maintenance of the principles of exhaustion of rights between the UK and the remainder of the EU of 27.

Read the full BAEPD Submission